Group 1 - The core viewpoint of the article is that Zhongyuan Securities (601375.SH) reported significant financial growth in its 2025 annual report, with notable increases in revenue and profit metrics [1] - The company achieved operating revenue of 1.963 billion yuan, representing a year-on-year growth of 40.97% [1] - The total profit reached 597 million yuan, marking a substantial year-on-year increase of 153.58% [1] - The net profit attributable to shareholders was 456 million yuan, which reflects an 85.41% year-on-year growth [1] - The company proposed a cash dividend of 0.22 yuan per 10 shares (tax included) [1]

Core Viewpoint - Lixin Development (00488.HK) reported a revenue of HKD 2.584 billion for the year ending December 31, 2025, representing a year-on-year increase of 1.4%. However, the company experienced a significant adjusted EBITDA decline of 23.3% to HKD 379 million, alongside a substantial net loss attributable to shareholders of HKD 1.167 billion, compared to a net loss of HKD 118 million in the same period last year [1]. Financial Performance - The company achieved a revenue of HKD 2.584 billion, which is a 1.4% increase year-on-year [1]. - Adjusted EBITDA for the group was HKD 379 million, reflecting a decrease of 23.3% compared to the previous year [1]. - The net loss attributable to shareholders was HKD 1.167 billion, a significant increase from the net loss of HKD 118 million in the prior year [1]. Loss Drivers - The increase in net loss was primarily due to several factors: 1. The sale of a residential building (T1) and the write-down of properties (mainly T3) in the Hengqin Innovation Phase II by Lifen Group [1]. 2. Fair value losses on investment properties held by the group [1]. 3. Fair value losses and impairment losses on properties held by joint ventures [1].

Core Viewpoint - Luoyang Molybdenum Co., Ltd. reported a slight decline in revenue for the year 2025, while showing significant growth in profit metrics [1] Financial Performance - The company achieved an operating revenue of 206.68 billion yuan, a year-on-year decrease of 2.98% [1] - The total profit reached 35.16 billion yuan, reflecting a year-on-year increase of 39.95% [1] - The net profit attributable to shareholders was 20.34 billion yuan, marking a year-on-year growth of 50.30% [1] Dividend Distribution - The company proposed a cash dividend of 2.86 yuan (including tax) for every 10 shares to all shareholders [1]

公司的候选药物中，有七种处于临床开发阶段，正在针对二十余种适应症进行临床开发。公司的两种已 商业化的药物泰它西普(RC18，商品名：泰爱®)和维迪西妥单抗(RC48，商品名：爱地希®)正于中国及 美国进行针对二十余种适应症的临床试验。 公司是一家全产业链一体化的生物制药公司，致力于发现、开发和商业化创新的、有特色的生物药，用 于治疗中国乃至全球多种医疗需求未被满足的自身免疫、肿瘤科和眼科疾病。公司的愿景是成为全球生 物制药行业的领军企业。 自2008年成立以来，公司一直致力于研发针对新的靶点、具有创新设计及具有突破性潜力的生物药，以 应对全球未被满足的临床需求。经过超过十年的不懈努力，公司已建立了全面一体化、端到端的药物开 发能力，涵盖了所有关键的生物药开发功能，包括发现、临床前药理学、工艺及质量开发、临床开发及 符合全球药品生产质量管理规范(GMP)的生产。依托于公司强大的研发平台，公司发现及开发了拥有超 过十种候选药物的完善产品线。 格隆汇3月27日丨荣昌生物(09995.HK)公告，截至2025年12月31日止年度，集团收益为人民币32.42亿 元，毛利为人民币28.16亿元。年度利润人民币7.10亿元 ...

Group 1 - The net buying and selling activities in the stock market show significant movements, with notable net purchases in Pop Mart (4.57 billion), Meituan (3.4 billion), and Changfei Optical Fiber (2.27 billion), while major net sales were observed in the Yingfu Fund (35.56 billion) and Alibaba (6.56 billion) [1][4] - Southbound funds have continuously net bought Changfei Optical Fiber for five days, totaling 20.6342 billion HKD, and Meituan for three days, totaling 27.3957 billion HKD, while net selling of SMIC has persisted for ten days, amounting to 45.1577 billion HKD [4] Group 2 - Pop Mart reported a revenue of 37.12 billion in 2025, a year-on-year increase of 184.7%, with adjusted net profit reaching 13.08 billion, up 284.5% [5] - Tencent Holdings repurchased 610,000 shares at a price between 488 and 498 HKD per share, totaling 3.01 billion HKD, and announced upgrades to its cloud services [5] - Xiaomi Group's advancements in robotics include a new dexterous hand capable of high-precision tasks, having passed 150,000 grip cycle reliability tests [6] - SMIC achieved a revenue of 67.323 billion in 2025, a 16.49% increase, with a net profit of 5.041 billion, up 36.29% [6] - Innovent Biologics reported total revenue of 13.0415 billion in 2025, a 38.4% increase, and turned a profit for the first time with a net profit of 0.8136 billion [6] - Ganfeng Lithium's domestic energy storage cell production reached 119.09 GWh in early 2026, a 91% year-on-year increase, indicating a seasonal recovery in the electric vehicle market [7]

Core Viewpoints - In 2025, the company is projected to achieve revenue of 162.35 billion yuan (+4.0%), gross profit of 41.51 billion yuan (-1.6%), and net profit attributable to shareholders of 22.64 billion yuan (+1.2%). A final dividend of 1.65 HKD per share is recommended, with a payout ratio of approximately 65% [1][4] - Benefiting from the rise in electrolytic aluminum prices, the company expects a revenue of 162.35 billion yuan in 2025, with alumina revenue around 38.83 billion yuan (gross margin of approximately 22.2%) and aluminum alloy revenue of 106.10 billion yuan (gross margin of approximately 28.5%) [1][2] - The board has declared a final dividend of 1.65 HKD per share, maintaining a payout ratio of 65%. The company has consistently ensured shareholder rights since its listing, providing cash dividends annually [1][4] Revenue and Profitability - In 2025, the company anticipates aluminum alloy sales of 5.824 million tons (-0.2%) and alumina sales of 13.397 million tons (+22.7%). The selling price per ton for aluminum alloy is expected to be 18,200 yuan (+3.8%), while alumina's selling price is projected at 2,899 yuan (-15.2%) [2] - The cost per ton for aluminum alloy is expected to be 13,000 yuan (-1.5%), and for alumina, it is projected at 2,256 yuan (+2.2%) [2] Supply Chain and Cost Management - The supply of bauxite raw materials is stable, with approximately 74.6% sourced from Guinea, 8.5% from Indonesia, and 16.8% from Australia. The company is actively involved in bauxite mining projects in Guinea to ensure stable supply and cost advantages [3] - The company is optimizing its diversified energy structure and advancing its green low-carbon strategy, including the launch of the Yunnan green low-carbon demonstration industrial park and the "wind-solar-storage" integrated renewable energy project [3] Market Dynamics - The aluminum price has faced downward pressure but is expected to rise due to supply-side contractions, particularly in the Middle East, where production has decreased by 600,000 tons. Geopolitical tensions and rising energy prices in Europe are also contributing to a tightening supply-demand balance [4] - The company is projected to have net profits of 34.9 billion yuan, 38.3 billion yuan, and 40.2 billion yuan for 2026-2028, with corresponding PE ratios of 8.8, 8.0, and 7.6 times, respectively, leading to a "buy" rating based on its position and cost advantages in the alumina and electrolytic aluminum sectors [5]

Core Viewpoint - BYD Electronics (00285.HK) has established a Strategic and Sustainable Development Committee under its board, aimed at enhancing its strategic direction and sustainability efforts [1] Group 1 - The Strategic and Sustainable Development Committee consists of four members, including non-executive director Wang Chuanfu, two executive directors Wang Nianqiang and Jiang Xiangrong, and one independent non-executive director Wang Ying [1] - Wang Chuanfu has been appointed as the chairman of the Strategic and Sustainable Development Committee [1]

Core Viewpoint - BYD Electronics (00285.HK) reported a revenue of approximately RMB 179.48 billion for the fiscal year 2025, reflecting a year-on-year increase of about 1.22%. However, the profit attributable to shareholders decreased by approximately 17.61% to around RMB 3.515 billion, with earnings per share at RMB 1.56 and a proposed final dividend of RMB 0.156 per share [1] Business Summary - The smart terminal components business experienced a decline due to changes in customer demand, while the assembly business saw year-on-year growth [1] - The new energy vehicle product categories and shipment volumes increased, maintaining a high growth rate in this segment [1] - The server business showed steady growth, focusing on core products such as liquid cooling and power supplies, which are expected to drive new growth in AI computing infrastructure [1] - Despite macroeconomic challenges affecting consumer confidence, the company is actively consolidating its leadership position in the high-end product supply chain and expanding collaborations with domestic and international clients to ensure stable development in the smart terminal business [1] - The AI server business, which has been proactively cultivated, is experiencing rapid growth and is becoming a new driving force for the company's overall business growth [1] - Multiple automotive products have achieved high shipment growth, with the new energy vehicle segment continuing to show strong growth momentum [1]

格隆汇3月27日丨云游控股(00484.HK)公布年度业绩，2025年度，集团实现营业收入约人民币155.6百万 元，较去年增长88.4%。受2025年全球经济增长放缓、行业周期波动、国际贸易壁垒高企、科技行业竞 争加剧等多项国际及行业因素影响，收入表现未达初步预期。尽管如此，集团透过专注核心业务、持续 优化营运效率，并及时应对国际局势转变带来的挑战，在复杂多变的环境中展现出强劲的经营韧性。同 时，受游戏变现及人工智能技术布局投入增加、市场快速转变、全球供应链成本上升，以及全球金融市 场波动的间接影响等不利因素，集团确认净亏损约人民币47.2百万元，是科技与贸易相关行业面临的共 性压力的客观体现。 回顾2025年的行业格局及本集团的布局，监于当前全球经济复苏仍然乏力、市场不确定性未明显纾缓， 加上国际货币体系多元化、供应链区域化、人工智能技术深度应用等趋势持续影响，本集团将继续坚持 「科技+生态」双轮驱动策略，破解发展难题、拓展增长空间，并延续自2025年起实行的长远发展策 略，追求高质量增长。 ...

Group 1 - The company, China Biologic Products Holdings, announced that on March 27, 2026, a trustee will purchase an additional 4.65 million shares from the market [1]